1daj

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
==Overview==
==Overview==
-
The novel furopyrimidine, N-(4-{N-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)methyl]methylamino}benzoyl), -L- glutamate (MTXO), a classical antifolate with antitumor activity, comparable to that of methotrexate (MTX), has been studied as, inhibitor-cofactor ternary crystal complexes with wild-type Pneumocystis, carinii (pc) and recombinant human wild-type dihydrofolate reductase, (hDHFR). These structural data provide the first direct comparison of the, binding interactions of the same antifolate inhibitor in the active site, for pc and human DHFR. The human ternary DHFR complex crystallizes in the, rhombohedral space group R3 and is isomorphous to the ternary complex, reported for a gamma-tetrazole methotrexate analogue, MTXT. The pcDHFR, complex crystallizes in the monoclinic space group ... [[http://ispc.weizmann.ac.il/pmbin/getpm?15299851 (full description)]]
+
The novel furopyrimidine, N-(4-{N-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)methyl]methylamino}benzoyl), -L- glutamate (MTXO), a classical antifolate with antitumor activity, comparable to that of methotrexate (MTX), has been studied as, inhibitor-cofactor ternary crystal complexes with wild-type Pneumocystis, carinii (pc) and recombinant human wild-type dihydrofolate reductase, (hDHFR). These structural data provide the first direct comparison of the, binding interactions of the same antifolate inhibitor in the active site, for pc and human DHFR. The human ternary DHFR complex crystallizes in the, rhombohedral space group R3 and is isomorphous to the ternary complex, reported for a gamma-tetrazole methotrexate analogue, MTXT. The pcDHFR, complex crystallizes in the monoclinic space group P2(1) and is, isomorphous to that reported for a trimethoprim (TMP) complex., Interpretation of difference Fourier electron-density maps for these, ternary complexes revealed that MTXO binds with its, 2,4-diaminofuropyrimidine ring interacting with Glu32 in pc and Glu30 in, human DHFR, as observed for MTXT. The presence of the 6-5 furopyrimidine, ring instead of the 6-6 pteridine ring results in a different bridge, conformation compared with that of MTXT. The bridge torsion angles for, MTXO, i.e. C(4a)-C(5)-C(8)-N(9) and C(5)-C(8)-N(9)-C(1'), are -156.5/51.9, degrees and -162.6/51.8 degrees, respectively for h and pc, compared with, -146.8/57.4 degrees for MTXT. In each case, the p-aminobenzoylglutamate, conformation is similar to that observed for MTXT. In the pcDHFR complex, the active-site region is conserved and the additional 20 residues in the, sequence compared with the human enzyme are located in external loop, regions. There is a significant change in the nicotinamide ribose, conformation of the cofactor which places the nicotinamide O atom close to, the 4NH(2) group of MTXO (2.7 A), a shift not observed in hDHFR, structures. As a consequence of this, there is a loss of a hydrogen bond, between the nicotinamide carbonyl group and the backbone of Ala12 in, pcDHFR. In the human ternary complexes, the cofactor NADPH is bound with a, more extended conformation, and the nicotinamide O atom makes a 3.5 A, contact with the 4NH(2) group of MTXO. Although the novel classical, antifolate MTXO is not highly active against pcDHFR, there are, correlations between its binding interactions consistent with its lower, potency as an inhibitor of h and pcDHFR compared with MTX.
==About this Structure==
==About this Structure==
-
1DAJ is a [[http://en.wikipedia.org/wiki/Single_protein Single protein]] structure of sequence from [[http://en.wikipedia.org/wiki/Pneumocystis_carinii Pneumocystis carinii]] with NDP and MOT as [[http://en.wikipedia.org/wiki/ligands ligands]]. Active as [[http://en.wikipedia.org/wiki/Dihydrofolate_reductase Dihydrofolate reductase]], with EC number [[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.3 1.5.1.3]]. Structure known Active Site: S1. Full crystallographic information is available from [[http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DAJ OCA]].
+
1DAJ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Pneumocystis_carinii Pneumocystis carinii] with NDP and MOT as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Dihydrofolate_reductase Dihydrofolate reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.3 1.5.1.3] Structure known Active Site: S1. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DAJ OCA].
==Reference==
==Reference==
Line 27: Line 27:
[[Category: oxidoreductase]]
[[Category: oxidoreductase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 15:00:51 2007''
+
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 14:58:04 2007''

Revision as of 12:52, 5 November 2007


1daj, resolution 2.30Å

Drag the structure with the mouse to rotate

COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS CARINII AND WILD TYPE HUMAN DIHYDROFOLATE REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[2,3D]PYRIMIDINE ANTIFOLATE

Overview

The novel furopyrimidine, N-(4-{N-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)methyl]methylamino}benzoyl), -L- glutamate (MTXO), a classical antifolate with antitumor activity, comparable to that of methotrexate (MTX), has been studied as, inhibitor-cofactor ternary crystal complexes with wild-type Pneumocystis, carinii (pc) and recombinant human wild-type dihydrofolate reductase, (hDHFR). These structural data provide the first direct comparison of the, binding interactions of the same antifolate inhibitor in the active site, for pc and human DHFR. The human ternary DHFR complex crystallizes in the, rhombohedral space group R3 and is isomorphous to the ternary complex, reported for a gamma-tetrazole methotrexate analogue, MTXT. The pcDHFR, complex crystallizes in the monoclinic space group P2(1) and is, isomorphous to that reported for a trimethoprim (TMP) complex., Interpretation of difference Fourier electron-density maps for these, ternary complexes revealed that MTXO binds with its, 2,4-diaminofuropyrimidine ring interacting with Glu32 in pc and Glu30 in, human DHFR, as observed for MTXT. The presence of the 6-5 furopyrimidine, ring instead of the 6-6 pteridine ring results in a different bridge, conformation compared with that of MTXT. The bridge torsion angles for, MTXO, i.e. C(4a)-C(5)-C(8)-N(9) and C(5)-C(8)-N(9)-C(1'), are -156.5/51.9, degrees and -162.6/51.8 degrees, respectively for h and pc, compared with, -146.8/57.4 degrees for MTXT. In each case, the p-aminobenzoylglutamate, conformation is similar to that observed for MTXT. In the pcDHFR complex, the active-site region is conserved and the additional 20 residues in the, sequence compared with the human enzyme are located in external loop, regions. There is a significant change in the nicotinamide ribose, conformation of the cofactor which places the nicotinamide O atom close to, the 4NH(2) group of MTXO (2.7 A), a shift not observed in hDHFR, structures. As a consequence of this, there is a loss of a hydrogen bond, between the nicotinamide carbonyl group and the backbone of Ala12 in, pcDHFR. In the human ternary complexes, the cofactor NADPH is bound with a, more extended conformation, and the nicotinamide O atom makes a 3.5 A, contact with the 4NH(2) group of MTXO. Although the novel classical, antifolate MTXO is not highly active against pcDHFR, there are, correlations between its binding interactions consistent with its lower, potency as an inhibitor of h and pcDHFR compared with MTX.

About this Structure

1DAJ is a Single protein structure of sequence from Pneumocystis carinii with NDP and MOT as ligands. Active as Dihydrofolate reductase, with EC number 1.5.1.3 Structure known Active Site: S1. Full crystallographic information is available from OCA.

Reference

Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate., Cody V, Galitsky N, Luft JR, Pangborn W, Gangjee A, Devraj R, Queener SF, Blakley RL, Acta Crystallogr D Biol Crystallogr. 1997 Nov 1;53(Pt 6):638-49. PMID:15299851

Page seeded by OCA on Mon Nov 5 14:58:04 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools